STAT+ Leukemia Drug Shows Remarkable Results
- As much of the nation battles frigid temperatures, the focus for hematologists worldwide is shifting to Orlando, Florida, where the American Society of Hematology (ASH) annual meeting is...
- Over the next four days, expect a concentrated stream of new data, analysis, and firsthand reporting from the meeting. The ASH annual meeting is a critical event for...
- We will be providing continuous updates and in-depth coverage of key presentations and discussions from ASH 2025.
Hematology’s Leading Minds Gather in Orlando: What to Expect from ASH 2025
As much of the nation battles frigid temperatures, the focus for hematologists worldwide is shifting to Orlando, Florida, where the American Society of Hematology (ASH) annual meeting is underway. With temperatures in the low 80s as of December 6, 2025, researchers and clinicians are converging to share the latest advancements in the understanding, diagnosis, and treatment of blood disorders.
A Four-Day Deep Dive into Blood Disorders
Over the next four days, expect a concentrated stream of new data, analysis, and firsthand reporting from the meeting. The ASH annual meeting is a critical event for those involved in the care of patients with conditions like leukemia, lymphoma, anemia, and clotting disorders. it’s a place where groundbreaking research is unveiled and future treatment strategies are debated.
Stay Informed with Ongoing Coverage
We will be providing continuous updates and in-depth coverage of key presentations and discussions from ASH 2025. This includes insights into emerging therapies, clinical trial results, and the evolving landscape of hematologic malignancies and benign hematologic conditions. For those seeking a curated summary delivered directly to your inbox, a sign-up for email updates is available here.
Updated December 7, 2025, at 05:47:16 AM EST.
